Physician profile
Lawrence E Weiss
NPI 1033116421
$2,042.68
in general payments reported to CMS, 2019-2025
10 companies · $243 in 2025
The $243 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $192 · 2022: $14.35 · 2023: $68.51 · 2024: $1,344 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,010 · Food and Beverage: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,009.63 |
| Food and Beverage | $646.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novus Surgical Consultants | $945.98 | 2023-2025 | |
| Arthrex, INC. | $690.30 | 2020-2024 | |
| Depuy Synthes Sales INC. | $112.70 | 2019 | |
| Electronic Waveform Lab, INC. | $85.99 | 2020-2025 | |
| Stryker Corporation | $64.39 | 2019-2023 | Variax |
| Endo Pharmaceuticals INC. | $36.02 | 2019 | |
| Bioventus LLC | $33.47 | 2023 | Exogen Ultrasound Bone Healing System |
| Axogen | $29.19 | 2020-2022 | |
| Janssen Biotech, INC. | $27.45 | 2024 | Tremfya |
| Medartis INC. | $17.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.